SCHEMBL9517971

SCHEMBL9517971

CCCCOc1ccc(C(O)CS(=O)(=O)NC(=O)c2ccc(COC(C)=O)nc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.38
MMP1 P03956 2/20 0.38
MAPK1 P28482 1/20 0.38
LMNA P02545 3/20 0.38
GAA P10253 2/20 0.38
STAT3 P40763 1/20 0.38
ADRB2 P07550 1/20 0.37
ADRB1 P08588 1/20 0.37
ADRB3 P13945 1/20 0.37
HPGD P15428 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TLR4 O00206 1/20 0.37
TLR2 O60603 1/20 0.37
PPARG P37231 1/20 0.36
BCL2L1 Q07817 1/20 0.36
MCL1 Q07820 1/20 0.36
HSP90AA1 P07900 1/20 0.36
MAPT P10636 1/20 0.36
HTT P42858 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9516318 0.93 PPARG (0.37) SMN1; SMN2MMP1MAPK1LMNAGAA
SCHEMBL9515466 0.91 SMN1; SMN2 (0.38) SMN1; SMN2MMP1MAPK1LMNAGAA
SCHEMBL9516886 0.89 MMP1 (0.40) SMN1; SMN2MMP1MAPK1LMNAGAA
SCHEMBL9517265 0.86 EGFR (0.41) SMN1; SMN2GABRA5
SCHEMBL9515611 0.86 EPHX2 (0.39)
SCHEMBL9517230 0.84 HSD11B1 (0.39) GAA
SCHEMBL9517963 0.83 TLR4 (0.38) SMN1; SMN2MMP1MAPK1LMNAGAA
SCHEMBL9517321 0.82 SCN9A (0.37) SMN1; SMN2ADRB2ADRB1ADRB3BCL2L1
SCHEMBL9517219 0.81 GABRA5 (0.38) SMN1; SMN2MMP1MAPK1LMNAGAA
SCHEMBL9516196 0.81 GABRA5 (0.50) SMN1; SMN2GAAHPGDTLR4TLR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567997-A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical HOECHST AKTIENGESELLSCHAFT (DE) 1993-11-03 EP disclosed